Abstract:Abstract Background According to the latest data released in 2018, it is estimated that there will be 18.1 million new cancer cases worldwide (excluding 1.7 million non-melanoma skin cancers) and 9.6 million cancer deaths (excluding 950 non-melanoma skin cancers) Million cases). Among them, the incidence of lung cancer (11.6% of the total number of cases) and mortality (18.4% of the total number of cancer deaths, which are expected to cause 1.8 million deaths) are the first. In recent years, studies have found TM4SF1 play an important role in the development process of many tumors. Methods Sixty-one patients with NSCLC who underwent surgical resection of cancer tissues, para-carcinoma tissues, and 10 normal lung tissues removed from benign lung disease (Jun/2018-Dec/2018) were collected. Real-time immunofluorescence quantitative PCR (qRT-PCR) and Western blot were used to detect the expression of TM4SF1 in NSCLC tissues (CT), para-carcinoma tissue (PCT), and normal lung tissues(NLT). TM4SF1 gene was overexpressed in lung cancer A549 cells using lentiviral transfection technology, qRT-PCR and Western blot were used to detect whether TM4SF1 gene was successfully expressed in lung cancer A549 cells, and Transwell was used to detect the effect of TM4SF1 overexpression on A549 migration. JAK2-STAT3 signal pathway interference reagent AG490 was used to analyze the expression levels of Stat3 and downstream Sox2 genes in the overexpression group, blank group, negative control group and their corresponding treatment groups TM4SF1, JAK2-STAT3 signal pathway using real-time qRT-PCR. Analyze the relevance of these three indicators at the same time. Results The expression levels of TM4SF1 mRNA and protein in cancer tissues were significantly higher than those in adjacent cancer tissues (P<0.05) and normal lung tissue specimens (P <0.05). The expression of TM4SF1 was not significantly associated with the age and sex of patients, but was associated with tumor size, degree of differentiation, lymph node metastasis, and clinical stage were related (P<0.05). TM4SF1 was successfully overexpressed in A549 cells. After overexpressing TM4SF1, the ability to migrate of A549 cells was significantly enhanced, and the expression levels of Stat3 and downstream Sox2 in the JAK2-STAT3 signaling pathway were up-regulated. The expression of TM4SF1, Stat3 and Sox2 at the mRNA level showed a positive correlation trend (P<0.01). Conclusion TM4SF1 is highly expressed in NSCLC, and its expression level is closely related to many clinical staging indicators. Overexpression of this gene can promote the migration of A549 cells and up-regulate the expression levels of Stat3 and downstream Sox2 in the JAK2-STAT3 signaling pathway. The expressions of TM4SF1, Stat3 and Sox2 were positively correlated in A549 cells. TM4SF1 may promote the occurrence, development and distant metastasis of NSCLC through this pathway. TM4SF1 may become a potential therapeutic target for NSCLC.

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6

TM4SF3 promotes esophageal carcinoma metastasis via upregulating ADAM12m expression

A High Level of Tm4sf5 is Associated with Human Esophageal Cancer Progression and Poor Patient Survival

Role of Transmembrane 4 L Six Family 1 in the Development and Progression of Cancer

Transmembrane-4 L-six Family Member-1 (TM4SF1) Promotes Non-Small Cell Lung Cancer Proliferation, Invasion and Chemo-Resistance Through Regulating the DDR1/Akt/ERK-mTOR Axis

TM4SF1 Promotes Metastasis of Pancreatic Cancer Via Regulating the Expression of DDR1

TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells

TM4SF1 Facilitates Non-Small Cell Lung Cancer Progression Through Regulating YAP-TEAD Pathway

TM4SF1 Regulates Pancreatic Cancer Migration and Invasion in Vitro and in Vivo

TRAF6 Promoted the Tumorigenicity of Esophageal Squamous Cell Carcinoma

S100A4 Mediated Cell Invasion and Metastasis of Esophageal Squamous Cell Carcinoma Via the Regulation of MMP-2 and E-cadherin Activity.

The Role of TMEM26 in Disrupting Tight Junctions and Activating NF-κB Signaling to Promote Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma.

Expression of Integrin β6 and HAX-1 Correlates with Aggressive Features and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer

FGF1-FGFR1 Axis Promotes Tongue Squamous Cell Carcinoma (TSCC) Metastasis Through Epithelial-Mesenchymal Transition (EMT).

LAMC1 upregulation via TGFβ induces inflammatory cancer‐associated fibroblasts in esophageal squamous cell carcinoma via NF‐κB–CXCL1–STAT3

TRAF6 regulates tumour metastasis through EMT and CSC phenotypes in head and neck squamous cell carcinoma.

Co‐targeting FAK and Gli1 Inhibits the Tumor‐associated Macrophages‐released CCL22‐mediated Esophageal Squamous Cell Carcinoma Malignancy

Mechanism of interaction between TM4SF1 and jak2-stat3 signaling pathway in lung cancer cells and expression analysis in non-small cell lung cancer

An ADAM12 and FAK Positive Feedback Loop Amplifies the Interaction Signal of Tumor Cells with Extracellular Matrix to Promote Esophageal Cancer Metastasis.

LAMC1, Upregulated by TGFβ in Tumor Cells, Contributed to The Formation of Inflammatory Cancer-Associated Fibroblasts Via NF-kB/CXCL1/STAT3 in Esophageal Squamous Cell Carcinoma.